SMAD3 and neoplasm: Finally, we carried out IHC for phosphorylated SMAD family member 3 (pSMAD3-ser425) as a surrogate for TGFβ signalling activation status in the tumours in a subset of the initial L1-IHC cohort (Fig. 2c).